Abbott Laboratories Total Assets 2006-2019 | ABT

Abbott Laboratories total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Abbott Laboratories total assets for the quarter ending June 30, 2019 were $68.427B, a 0.02% increase year-over-year.
  • Abbott Laboratories total assets for 2018 were $67.173B, a 11.9% decline from 2017.
  • Abbott Laboratories total assets for 2017 were $76.25B, a 44.78% increase from 2016.
  • Abbott Laboratories total assets for 2016 were $52.666B, a 27.68% increase from 2015.
Abbott Laboratories Annual Total Assets
(Millions of US $)
2018 $67,173
2017 $76,250
2016 $52,666
2015 $41,247
2014 $41,207
2013 $42,953
2012 $67,235
2011 $60,277
2010 $60,574
2009 $52,582
2008 $42,419
2007 $39,714
2006 $36,178
2005 $29,141
Abbott Laboratories Quarterly Total Assets
(Millions of US $)
Q2 2019 $68,427
Q1 2019 $67,610
Q4 2018 $67,173
Q3 2018 $71,637
Q2 2018 $68,415
Q1 2018 $70,908
Q4 2017 $76,250
Q3 2017 $72,248
Q2 2017 $71,151
Q1 2017 $70,887
Q4 2016 $52,666
Q3 2016 $39,497
Q2 2016 $39,831
Q1 2016 $39,637
Q4 2015 $41,247
Q3 2015 $41,725
Q2 2015 $44,125
Q1 2015 $43,095
Q4 2014 $41,207
Q3 2014 $42,514
Q2 2014 $41,475
Q1 2014 $41,662
Q4 2013 $42,953
Q3 2013 $44,132
Q2 2013 $42,903
Q1 2013 $42,687
Q4 2012 $67,235
Q3 2012 $63,258
Q2 2012 $61,860
Q1 2012 $62,416
Q4 2011 $60,277
Q3 2011 $59,628
Q2 2011 $62,004
Q1 2011 $61,651
Q4 2010 $60,574
Q3 2010 $57,374
Q2 2010 $53,381
Q1 2010 $53,359
Q4 2009 $52,582
Q3 2009 $49,847
Q2 2009 $47,630
Q1 2009 $45,438
Q4 2008 $42,419
Q3 2008 $41,753
Q2 2008 $44,074
Q1 2008 $41,178
Q4 2007 $39,714
Q3 2007 $37,622
Q2 2007 $37,153
Q1 2007 $36,286
Q4 2006 $36,178
Q3 2006 $33,300
Q2 2006 $34,061
Q1 2006 $28,532
Q4 2005 $29,141
Q3 2005 $28,831
Q2 2005 $27,817
Q1 2005 $28,857
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $141.639B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Insulet (PODD) United States $9.336B 553.21
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
NuVasive (NUVA) United States $3.263B 26.01
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Cardiovascular Systems (CSII) United States $1.586B 0.00
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Fonar (FONR) United States $0.127B 8.93
Chimerix (CMRX) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00